Feature|Videos|September 6, 2000
Projecting Pharma's Outlook with Deloitte's Laks Pernenkil
Author(s)Grant Playter
Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry.
Advertisement
Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry with Grant Playter, associate editor. Topics of discussion include Deloitte’s recent report on the state of biopharma, broader digitalization trends, how generative AI will affect pharma going forward, the push toward supply chain resilience, and more.
About the speaker
[insert text]
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
2
What to Know from the FDA’s End of August Activity
3
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
4
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
5